PRIVISCLBSEPRIVI SPECIALITY CHE LTD· Chemicals & PetrochemicalsHighPositive
Announced Thu, 29 Oct, 2026 · 13:36 IST

Q2 profit up 30%, Rs 5 dividend and Rs 2.97 crore solar plan

Pat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

PRIVISCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.6%Reaction day
₹3474.90
prior close
₹3510.90
announcement price
In-mkt
timing
Nifty Smallcap 250market+0.7%-5.3% vs market
Specialty Chemicals peers, median of 99sector+0.4%-5.0% vs sector

On the reaction day the stock moved 5.3 pts less than Nifty Smallcap 250 and 5.0 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.1
10m
-1.9
15m
-3.8
30m
-3.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.6+0.7-5.3+0.4-5.0
Next day
-5.8pendingpending-1.7-4.1
2d
—————
3d
—————
4d
—————
5d
—————
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 99Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved Q2 FY27 and H1 FY27 results, reviewed without qualification. Consolidated Q2 revenue was Rs 760.45 crore, up 12% year on year, and net profit was Rs 117.53 crore, up 30%. H1 revenue was Rs 1,426.67 crore and profit was Rs 200.37 crore, up 36%. A Rs 5 per share interim dividend has a Nov 4 record date and is payable by Nov 25. The board also approved up to Rs 2.97 crore for a Gujarat wind-solar project.

Likely market impact

Profit growth and dividend may support sentiment, though payout uses cash. Project spending is modest; execution and returns remain watch points.